HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jan. 31, 2019--
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it
plans to release its financial results for the quarter ended December
31, 2018, after the close of market on Wednesday, February 6, 2019.
The release will be accessible on Taro’s website at www.taro.com.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based
pharmaceutical company, dedicated to meeting the needs of its customers
through the discovery, development, manufacturing and marketing of the
highest quality healthcare products. For further information on Taro
Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190131005824/en/
Source: Taro Pharmaceutical Industries Ltd.
VP, Chief Financial Officer
William J. Coote
AVP, Business Finance, Treasurer and